-
Part 1 | Session 4 Dr Zahr on the Evolution of Intrepid TTVR and the Next Pivotal Trial
-
Part 1 | Session 1 Welcome and Introduction
In this episode of Nail it with Nadira, Dr Susheel Kodali discusses the VDyne TTVR system, a next-generation transcatheter tricuspid valve replacement platform designed to conform to native anatomy, support a low-profile implant, and offer fully repositionable, leaflet-independent deployment.
The conversation covers the device design, implant technique, early clinical experience, and the practical considerations that may shape the future of tricuspid regurgitation treatment.
This chapter gives structural heart specialists a concise, expert-level look at a new TTVR system and the features that could matter most in real-world practice, including deliverability, retrievability, conduction considerations, and how the platform may fit into the expanding treatment landscape for severe tricuspid regurgitation.
Part of the Nail It with Nadira series, this programme explores the rapidly evolving field of transcatheter tricuspid valve replacement (TTVR) through practical, expert-led discussions.
Join Dr Nadira Hamid, Prof Nicolas Van Mieghem, Dr Firas Zahr, Dr Susheel Kodali, Dr Neil Fam and Dr Kashish Goel as they examine emerging TTVR technologies, including Intrepid, VDyne, Topaz, LuX and Laplace. Across a series of focused segments, the faculty discuss patient selection, imaging, procedural planning, device design and the role of TTVR within contemporary tricuspid treatment pathways.
Designed for structural heart specialists and Heart Team members, the series provides practical insights into how leading centres are evaluating and preparing to integrate next-generation TTVR platforms into clinical practice.
Watch the episodes, explore the latest developments in tricuspid intervention and join the conversation by sharing your perspectives on the future of TTVR.
More from this programme
Part 1
Faculty Biographies
Susheel Kodali
Director of the Structural Heart and Valve Center and Professor in medicine
Dr Susheel Kodali is the Director of the Structural Heart and Valve Center and a Professor in Medicine at Columbia University Medical Center. Dr Kodali attended medical school at UCLA before completing two fellowships in clinical and interventional cardiology at the UCSF Medical Centre and Columbia University Irving Medical Center.
Dr. Kodali specialises in the percutaneous treatment of coronary artery and structural heart disease, including angioplasty and TAVR. He also serves as co-investigator of the PARTNER trials and is part of the trial steering committee.
Comments